[Comment] Meningococcal B resurgence in the UK: implications

[Comment] Meningococcal B resurgence in the UK: implications for updating global vaccine strategies

Invasive meningococcal disease caused by Neisseria meningitidis is primarily associated with serogroups A, B, C, W, X, and Y and is characterised by its sudden, unpredictable nature and devastating consequences, predominantly affecting children, adolescents, and young adults.1,2 Case-fatality rates range from 5–10% in Europe but can reach up to 15% despite appropriate treatment, particularly in severe septicaemic disease.3 Approximately 10–25% of survivors experience disabling long-term sequelae